Use of biomarkers in Alzheimer’s trials

被引：0
|
作者：
B. Vellas
机构：
[1] CHU Toulouse,Gérontopôle, U 558, Alzheimer’s Disease Clinical Research Center
来源：
JNHA - The Journal of Nutrition, Health and Aging | 2009年 / 13卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：331 / 331
相关论文
共 50 条
  • [1] Use of biomarkers in Alzheimer's trials
    Vellas, B.
    JOURNAL OF NUTRITION HEALTH & AGING, 2009, 13 (04): : 331 - 331
  • [2] Insights into the use of biomarkers in clinical trials in Alzheimer's ' s disease
    Pascoal, Tharick A.
    Aguzzoli, Cristiano S.
    Lussier, Firoza Z.
    Crivelli, Lucia
    Suemoto, Claudia K.
    Fortea, Juan
    Rosa-Neto, Pedro
    Zimmer, Eduardo R.
    Ferreira, Pamela C. L.
    Bellaver, Bruna
    EBIOMEDICINE, 2024, 108
  • [3] Use of CSF biomarkers in Alzheimer’s disease clinical trials
    K. Blennow
    H. Zetterberg
    JNHA - The Journal of Nutrition, Health and Aging, 2009, 13
  • [4] Use of CSF biomarkers in Alzheimer's disease clinical trials
    Blennow, K.
    Zetterberg, H.
    JOURNAL OF NUTRITION HEALTH & AGING, 2009, 13 (04): : 358 - 361
  • [5] Biomarkers for Alzheimer's disease therapeutic trials
    Hampel, Harald
    Wilcock, Gordon
    Andrieu, Sandrine
    Aisen, Paul
    Blennow, Kaj
    Broich, K.
    Carrillo, Maria
    Fox, Nick C.
    Frisoni, Giovanni B.
    Isaac, Maria
    Lovestone, Simon
    Nordberg, Agneta
    Prvulovic, David
    Sampaio, Christina
    Scheltens, Philip
    Weiner, Michael
    Winblad, Bengt
    Coley, Nicola
    Vellas, Bruno
    PROGRESS IN NEUROBIOLOGY, 2011, 95 (04) : 579 - 593
  • [6] Biomarkers for Alzheimer's disease trials - biomarkers for what? A discussion paper
    Lovestone, S.
    Thambisetty, M.
    JOURNAL OF NUTRITION HEALTH & AGING, 2009, 13 (04): : 334 - 336
  • [7] Biomarkers for Alzheimer’s disease trials — biomarkers for what? A discussion paper
    S. Lovestone
    M. Thambisetty
    JNHA - The Journal of Nutrition, Health and Aging, 2009, 13 : 334 - 336
  • [8] Biomarkers as Endpoints in Clinical Trials for Alzheimer's Disease
    Elghanam, Yomna
    Purja, Sujata
    Kim, Eun Young
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 99 (02) : 693 - 703
  • [9] Use of Biomarkers in Clinical Trials of Alzheimer DiseaseFrom Concept to Application
    Liyong Wu
    Pedro Rosa-Neto
    Serge Gauthier
    Molecular Diagnosis & Therapy, 2011, 15 : 313 - 325
  • [10] The use of cerebrospinal fluid biomarkers to measure change in neurodegeneration in Alzheimer's disease clinical trials
    Olsson, Bob
    Schott, Jonathan M.
    Blennow, Kaj
    Zetterberg, Henrik
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2017, 17 (08) : 767 - 775
12345